- Home
- ATCX vs SCNX Comparison
ATCX vs SCNX Comparison
Compare ATCX & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATCX | SCNX |
|---|---|---|
| Founded | 2016 | 2010 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | | Other Pharmaceuticals |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.8M | 16.2M |
| IPO Year | 2016 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ATCX | SCNX |
|---|---|---|
| Price | $3.12 | $0.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $13.75 | $1.50 |
| AVG Volume (30 Days) | 6.5K | ★ 609.4K |
| Earning Date | 03-16-2023 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,831,778.00 |
| Revenue This Year | $827,667.00 | $1,097.38 |
| Revenue Next Year | $166.45 | $239.80 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 30.72 |
| 52 Week Low | $2.57 | $0.24 |
| 52 Week High | $14.01 | $2.60 |
Technical Indicators
Market Signals| Indicator | ATCX | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 39.81 | 23.28 |
| Support Level | $2.88 | $0.24 |
| Resistance Level | $3.26 | $0.43 |
| Average True Range (ATR) | 0.18 | 0.02 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 38.89 | 7.47 |
Price Performance
Historical ComparisonAbout ATCX Atlas Critical Minerals Corporation Common Stock
Atlas Critical Minerals Corp is a mineral exploration and development company focused on critical minerals projects and properties in Brazil. The company's portfolio principally includes mineral properties for rare earths, graphite, titanium, copper, uranium, and nickel. It also owns mineral rights for iron ore, quartzite, gold, and diamond properties. The company's project portfolio includes the Alto Paranaiba, Malacacheta, Arcos, Goias, Tocantins, Rio Piracicaba, and other projects.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.